Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States

Journal of Infectious Diseases

Volumn 204, Issue 7, 2011, Pages 980-986

  Lopman, Ben A ^a   Curns, Aaron T ^a   Yen, Catherine ^a   Parashar, Umesh D ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISPANIC; HOSPITAL DISCHARGE; HOSPITALIZATION COST; HUMAN; HUMAN ROTAVIRUS; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS INFECTION; SCHOOL CHILD; SEASONAL VARIATION; SPRING; UNITED STATES; VIRAL GASTROENTERITIS; VIRUS TRANSMISSION; WINTER;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DIARRHEA; FEMALE; GASTROENTERITIS; HOSPITALIZATION; HUMANS; IMMUNITY, HERD; INFANT; MALE; MIDDLE AGED; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; TIME FACTORS; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 80052422557     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir492     Document Type: Article

References (24)

1. Parashar U.D., Alexander J.P., Glass R.I. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-13.
2. Postmarketingmonitoring of intussusception after RotaTeq vaccinationd United States, February 1, 2006-February 15, 2007. MMWR Morb Mortal Wkly Rep 2007; 56:218-222
3. Cortese M.M., Tate J.E., Simonsen L., Edelman L., Parashar U.D. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J 2010; 29:489-494
4. Vesikari T., Matson D.O., Dennehy P., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33. (Pubitemid 43048948)
5. Boom J.A., Tate J.E., Sahni L.C., et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010; 125:e199-e207
6. Wang F.T., Mast T.C., Glass R.J., Loughlin J., Seeger J.D. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics 2010; 125:e208-e213
7. Curns A.T., Steiner C.A., Barrett M., Hunter K., Wilson E., Parashar U.D. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: Analysis of hospital discharge data from 18 US states. J Infect Dis 2010; 201:1617-1624
8. Healthcare Cost, and Utilization Project. Introduction to the HCUP Nationwide Inpatient Sample (NIS). Rockville, MD: HCUP Central Distributor, 2008. http://www.hcup-us.ahrq.gov/db/nation/nis/NIS-2008-INTRODUCTION.pdf. Accessed 22 August 2011.
9. McCullagh P., Nelder J. Generalized linear models. London: Chapman and Hall, 1989.
10. Lopman B.A., Hall A.J. Curns A.T., Parashar U.D. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis 2011; 52:466-474
11. Tate J.E., Panozzo C.A., Payne D.C., et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009; 124:465-471
12. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination scheduledUnited States, February 2006-May 2007. MMWR Morb Mortal Wkly Rep 2008; 57:398-401.
13. National, state, and local area vaccination coverage among children aged 19-35 monthsdUnited States, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:1171-1177
14. Yen C., Steiner C.A., Barrett M., et al. Racial disparities in diarrhea-associated hospitalizations among children in five US states, before and after introduction of rotavirus vaccine. Vaccine 2010; 28:7423-7426
15. US Census Bureau. Census 2000 Summary File 2 (SF2). Washington, DC: US Census Bureau, 2000.
16. Koopman J.S., Monto A.S., Longini I.M. Jr. The Tecumseh study. XVI: Family and community sources of rotavirus infection. Am J Epidemiol 1989; 130:760-768 (Pubitemid 19240204)
17. Field E.J., Vally H., Grimwood K., Lambert S.B. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010; 126:e506-e512
18. Zeller M., Rahman M., Heylen E., et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine 2010; 28:7507-7513
19. Widdowson M.A., Meltzer M.I., Zhang X., Bresee J.S., Parashar U.D., Glass R.I. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007; 119:684-697 (Pubitemid 46556667)
20. Nelson E.A., Glass R.I. Rotavirus: Realising the potential of a promising vaccine. Lancet 2010; 376:568-570
21. Madhi S.A., Cunliffe N.A., Steele D., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-298
22. Patel M., Pedreira C., De Oliveira L.H., et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009; 301:2243-2251
23. Armah G.E., Sow S.O., Breiman R.F., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebocontrolled trial. Lancet 2010; 376:606-614
24. Zaman K., Dang D.A., Victor J.C., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: A randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615-623